Cardiac Transplant Completed Phase 2 Trials for Pioglitazone (DB01132)

Also known as: Heart Transplant / Heart Transplantation

IndicationStatusPhase
DBCOND0030027 (Cardiac Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01186250Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart TransplantationTreatment